Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg Read more
Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen U.S. footprint Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection Read more
OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status Read more
Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA in India to Advance Treatment of Hematological Malignancies Read more
PLUSS Advanced Technologies and Ecodome Logistics Unite to Build India’s Greenest, Most Reliable Cold-Chain for Pharmaceutical Distribution Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg Read more